Blue Clay Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2	Closed	-$11K	–	89
2016 Q2	$11K	Sell	2 -13	-87%	-$71.5K	0.01%	82
2016 Q1	$156K	Hold	15	–	–	0.15%	71
2015 Q4	$140K	Buy	+15	New	+$140K	0.12%	74